Neuroendocrine differentiation as a survival prognostic factor in advanced non-small cell lung cancer | Zendy

Marina Petrović | Zendy; Ilija Tomić | Zendy; Srbislav Ilić | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neuroendocrine differentiation as a survival prognostic factor in advanced non-small cell lung cancer

Author(s) -

Marina Petrović,

Ilija Tomić,

Srbislav Ilić

Publication year - 2007

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp0708525p

Subject(s) - chromogranin a , neuroendocrine differentiation , medicine , lung cancer , pleural effusion , stage (stratigraphy) , enolase , chemotherapy , adenocarcinoma , oncology , cancer , pathology , neuroendocrine tumors , immunohistochemistry , gastroenterology , biology , paleontology , prostate cancer

Neuroendrocine lung tumors are histologically heterogenous group of cancers with different clinical progression. In non-small cell lung cancer (NSCLC) neuroendocrine differentiation exists in 10-30% of patients. The aim of this study was to determine the frequency and influence of neuroendocrine differentiation on survival of treated patients with advanced non-small cell lung cancer (NSCLC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research